SafKan, Inc.

SafKan, Inc. is a US-based firm specializing in innovative ear care solutions through its OtoSet® Ear Cleaning System, designed to enhance ear hygiene for patients with ear-related issues. Founded in 2016 and headquartered in Redmond, US, SafKan, Inc. focuses on ear care solutions.

The company was founded by Aadil Diwan and Sahil Diwan. In December 2022, SafKan raised USD 12. 96 mn in Series A funding led by Unorthodox Ventures, with participation from several investors, bringing the total amount raised to USD 12. 96 mn and a current valuation of USD 26.

44 mn. SafKan Health specializes in the OtoSet® Ear Cleaning System, an innovative solution designed to address ear care and hygiene for individuals experiencing ear-related issues. This automated, FDA-cleared device utilizes a combination of irrigation and micro-suction technology to effectively break down and remove earwax buildup in a quick and mess-free manner. The OtoSet® system not only simplifies the ear cleaning process but also enhances user comfort, making it accessible for a wide range of patients.

The company primarily targets healthcare providers and clinics, offering their product to practitioners who can administer the service to patients seeking relief from earwax-related discomfort. Geographic markets for OtoSet® include urban centers across the United States, where demand for efficient and safe ear care solutions is pronounced. The revenue model for SafKan Health is built around the distribution of the OtoSet® Ear Cleaning System to certified clinics and healthcare facilities. Transactions are structured as direct sales to healthcare providers, who then offer ear cleaning services to their patients, creating a B2B transaction environment.

Additionally, the company may engage in partnerships with clinics that allow for collaborative promotion and use of the OtoSet® device in ear care treatments. While specific pricing details for the OtoSet® system are not disclosed, the device is positioned as a premium solution within the healthcare market, reflecting the innovative technology and added benefits it provides to both practitioners and patients. Through these transactions, SafKan Health aims to capture a significant share of the ear care market by providing a reliable and effective solution for ear hygiene. In December 2022, SafKan, Inc.

raised USD 12. 96 mn in Series A funding to support the development of its marketing and manufacturing activities. The company plans to design and launch new products within the ear care sector, focusing on enhancing patient access to effective ear hygiene solutions. SafKan aims to expand its market reach into additional urban centers across the United States by 2024, leveraging the recent funding to establish stronger partnerships with healthcare providers and increase distribution capabilities.